Teams link: Join the Meeting Now
Meeting ID: 234 297 242 669 890
Passcode: EG2uo7X8
Learning Objectives:
Describe the stages of cardiovascular-kidney-metabolic (CKM) syndrome and use the clinical criteria described in the 2026 AHA/ACC/ADA/ASN guideline to classify a patient's CKM syndrome stage based on their risk factors
Identify appropriate non-pharmacologic recommendations for patients based on their CKM stage and individual risk factors
Recognize when to recommend RAAS inhibitors, GLP-1 based therapies, MRAs, and SGLT-2 inhibitors for patients with overlapping CKM conditions
Session date:
11/12/2026 - 2:00pm to 3:00pm CST
Location:
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI
53705
United States
See map: Google Maps
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar:
Discloser List CME Internal Report
Presenter(s):
Megan Johnson
Lauren Koch
Mitchell Schumann

Facebook
X
LinkedIn
Forward